CATX vs CUBE · rev $2.2M vs P/E 25, rev $1.07B
Perspective Therapeutics Inc. (CATX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CATX currently screens at market cap $280.6M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CATX and CUBE stock pages for the full models.
Not investment advice.